In metastatic prostate cancer, AI-facilitated quantification of metastatic burden, accurate identification of castration resistance, and prediction of treatment sensitivity and resistance are active ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...
OMAHA, Neb. and BELGRADE, Maine, May 27, 2025 /PRNewswire/ -- The recent announcement that a former president of the United States developed late-stage prostate cancer is a distressing reminder of the ...
Prostate cancer is the most common form of cancer among men in Western countries. The disease is naturally linked to aging. Professor Tone Frost Bathen at NTNU leads a number of research projects on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results